Avita Medical Stock Fundamentals
| 51KB Stock | EUR 2.42 0.02 0.82% |
AVITA Medical fundamentals help investors to digest information that contributes to AVITA Medical's financial success or failures. It also enables traders to predict the movement of AVITA Stock. The fundamental analysis module provides a way to measure AVITA Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AVITA Medical stock.
AVITA |
AVITA Medical Company EBITDA Analysis
AVITA Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AVITA Medical EBITDA | (25.81 M) |
Most of AVITA Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AVITA Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AVITA Medical reported earnings before interest,tax, depreciation and amortization of (25.81 Million). This is much lower than that of the sector and significantly lower than that of the EBITDA industry. The ebitda for all Germany stocks is notably higher than that of the company.
AVITA Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AVITA Medical's current stock value. Our valuation model uses many indicators to compare AVITA Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AVITA Medical competition to find correlations between indicators driving AVITA Medical's intrinsic value. More Info.AVITA Medical is rated below average in current valuation category among its peers. It is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for AVITA Medical is about 49,305,846 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AVITA Medical's earnings, one of the primary drivers of an investment's value.AVITA EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AVITA Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AVITA Medical could also be used in its relative valuation, which is a method of valuing AVITA Medical by comparing valuation metrics of similar companies.AVITA Medical is currently under evaluation in ebitda category among its peers.
AVITA Fundamentals
| Current Valuation | 96.47 M | |||
| Price To Book | 1.96 X | |||
| Price To Sales | 5.19 X | |||
| Revenue | 29.23 M | |||
| EBITDA | (25.81 M) | |||
| Net Income | (26.58 M) | |||
| Cash Flow From Operations | (25.9 M) | |||
| Market Capitalization | 279.41 M | |||
| Total Asset | 125.5 M | |||
| Net Asset | 125.5 M |
About AVITA Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AVITA Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AVITA Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AVITA Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in AVITA Stock
When determining whether AVITA Medical is a strong investment it is important to analyze AVITA Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AVITA Medical's future performance. For an informed investment choice regarding AVITA Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AVITA Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in AVITA Stock please use our How to Invest in AVITA Medical guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.